Reportum - Pharmacovigilance Case Intake Platform - Qinecsa
Reportum® Platform
The market leading unified safety intake platform that captures adverse events at source, strengthens workflow control, and helps pharmacovigilance teams manage reporting efficiently at scale.
As adverse event volumes and reporting channels grow, pharmacovigilance teams need a more connected way to capture safety data. Reportum is Qinecsa’s unified safety intake platform, capturing adverse events at source across digital and analogue channels. It standardises intake across global stakeholders, reduces manual effort and improves data quality, helping life sciences organisations scale reporting operations while strengthening compliance, operational visibility and patient safety.
What Is Reportum® And Why It Matters
Reportum is Qinecsa’s pharmacovigilance reporting solution designed to streamline the generation, management and delivery of safety reports across global regulatory environments.
Safety reporting sits at the heart of pharmacovigilance. Organisations must generate periodic and aggregate reports such as PSURs, PBRERs, DSURs and signal-related reports while ensuring they meet regional regulatory expectations. These processes often involve multiple stakeholders, large volumes of safety data and complex timelines.
Without the right infrastructure, reporting can become fragmented, inefficient and difficult to manage. Manual processes increase the likelihood of inconsistencies and delays, while disconnected systems make it harder to maintain oversight and control.
Reportum addresses these challenges by providing a structured, technology-enabled reporting framework that integrates data, processes and expertise. The solution ensures that safety reports are produced accurately and efficiently, while maintaining the traceability, governance and quality expected by global regulators.
For pharmacovigilance leaders, this means greater visibility across reporting activities, improved operational control and stronger compliance with regulatory requirements in markets such as the EU, UK and US.
Key Features Of Our Reportum Solution
The Reportum platform incorporates several features designed specifically for pharmacovigilance reporting.
Structured reporting workflows
Reportum provides clear, repeatable workflows that guide safety reporting activities from data collection through to submission. This structured approach reduces the risk of delays or missed steps.
Integrated safety data access
The platform enables seamless access to safety data and reporting outputs, ensuring teams can quickly generate accurate reports without manual data consolidation.
Regulatory-aligned templates
Reportum includes templates and frameworks aligned with global pharmacovigilance regulations, supporting the preparation of reports required by authorities such as the EMA and FDA.
Centralised oversight and governance
Safety leaders gain visibility across all reporting activities, including timelines, responsibilities and progress tracking. This improves operational control and inspection readiness.
Scalable delivery model
Whether supporting a single product or a global portfolio, Reportum scales with your organisation’s pharmacovigilance needs.
Quality and compliance controls
Built-in quality checks and governance mechanisms ensure that all reports meet regulatory expectations and internal standards before submission.
Together, these features ensure that safety reporting becomes a controlled, efficient and reliable process rather than a reactive operational challenge.
Benefits of Reportum With Qinecsa
- Strengthens global pharmacovigilance compliance across EU, US and international regulatory frameworks
- Reduces regulatory risk by ensuring timely, accurate safety reporting
- Improves operational efficiency through structured workflows and automation
- Provides consistent reporting processes across products, affiliates and partners
- Enhances inspection readiness with clear governance and documentation
- Enables flexible reporting models through Reportum Design Studio, allowing organisations to configure intake forms, workflows and reporting experiences to match their operational and regulatory needs
Frequently Asked Questions About Reportum
What is Reportum in pharmacovigilance?
Reportum is Qinecsa’s pharmacovigilance reporting solution designed to streamline the creation and management of regulatory safety reports. It combines structured workflows, technology and expert support to ensure safety reports are produced efficiently and in compliance with global regulations.
How does Reportum improve pharmacovigilance reporting?
Reportum improves pharmacovigilance reporting by centralising data access, standardising workflows and providing governance across the reporting lifecycle. This helps organisations reduce manual processes, improve report quality and meet regulatory deadlines with confidence.
What types of reports can be produced using Reportum?
Reportum supports the generation of key pharmacovigilance reports including PSURs, PBRERs, DSURs and other regulatory safety documents. The platform can be configured to align with global regulatory reporting requirements.
Is Reportum suitable for global pharmacovigilance operations?
Yes. Reportum is designed to support global pharmacovigilance operations across multiple regulatory environments. It provides structured processes that help organisations maintain consistent reporting standards across regions.
How does Reportum support regulatory compliance?
Reportum supports compliance by embedding regulatory-aligned templates, governance controls and quality checks within the reporting process. This ensures reports meet the expectations of authorities such as the EMA and FDA.
Can Reportum integrate with existing safety databases?
Yes. Reportum can be configured to integrate with existing pharmacovigilance systems and safety databases. This enables efficient access to safety data and reduces the need for manual data consolidation.
Does Qinecsa provide operational support for Reportum?
Yes. Qinecsa can support organisations with both implementation and operational delivery of Reportum. Our teams can work alongside internal pharmacovigilance teams or manage reporting activities as part of a broader service model.
How does Reportum support inspection readiness?
Reportum supports inspection readiness by providing clear documentation, structured workflows and traceable reporting processes. This helps organisations demonstrate compliance during regulatory inspections.
Who should consider implementing Reportum?
Pharmaceutical, biotech and life sciences organisations that need to improve the efficiency, consistency and compliance of their pharmacovigilance reporting processes can benefit from Reportum.